SMD Rise PCLBKK:SMD100-R 59 PB Ratio is 1.77 as of Jun. 26, 2026, which is 39% above its 10-year median of 1.27. GuruFocus rates BKK:SMD100-R with a GF Score™ of 59/100 and a GF Value™ of ฿23.66. The stock has 6 warning signs investors should review. Among 112 Medical Distribution companies, SMD Rise PCL ranks better than 93.75% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-26), SMD Rise PCL's share price is ฿5.85. SMD Rise PCL's Book Value per Share for the quarter that ended in Mar. 2026 was ฿3.30. Hence, SMD Rise PCL's PB Ratio of today is 1.77.
Good Sign:
SMD Rise PCL stock PB Ratio (=0.34) is close to 10-year low of 0.34.
The historical rank and industry rank for SMD Rise PCL's PB Ratio or its related term are showing as below:
BKK:SMD100-R'
s PB Ratio Range Over the Past 10 Years
Min: 0.34 Med: 1.27 Max: 8.95
Current: 0.34
During the past 8 years, SMD Rise PCL's highest PB Ratio was 8.95. The lowest was 0.34. And the median was 1.27.
BKK:SMD100-R's PB Ratio is ranked better than 93.75% of 112
companies
in the Medical Distribution industry
Industry Median: 1.03
vs BKK:SMD100-R: 0.34
During the past 12 months, SMD Rise PCL's average Book Value Per Share Growth Rate was -6.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -9.00% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 18.20% per year.
During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of SMD Rise PCL was 67.40% per year. The lowest was -9.00% per year. And the median was 61.50% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
SMD Rise PCL PB Ratio Related Terms
SMD Rise PCL PB Ratio Historical Data
* Premium members only.
The historical data trend for SMD Rise PCL's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:SMD100-R vs MCK, COR, CAH: PB Ratio Comparison
For the Medical Distribution subindustry, SMD Rise PCL's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SMD Rise PCL PB Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, SMD Rise PCL's PB Ratio distribution charts can be found below:
* The bar in red indicates where SMD Rise PCL's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
SMD Rise PCL's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
SMD Rise PCL (BKK:SMD100-R) has a PB Ratio of 1.77 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on SMD Rise PCL and its competitors. This is 39% above median its historical median of 1.27. Over the past decade, SMD Rise PCL's PB Ratio has ranged from 0.34 to 8.95. According to the industry distribution chart, SMD Rise PCL ranks #7 out of 112 companies in the Medical Distribution industry, placing it in the top 6.2%.
Is SMD Rise PCL's PB Ratio too high?
SMD Rise PCL's current PB Ratio of 1.77 is 39% above median its 10-year median of 1.27. Over the past 10 years, this metric has ranged from a low of 0.34 to a high of 8.95. The Medical Distribution industry median PB Ratio is 1.03. SMD Rise PCL's value of 1.77 is 71.8% above this industry median. Based on the distribution chart, SMD Rise PCL ranks #7 out of 112 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, SMD Rise PCL has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does SMD Rise PCL's PB Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, SMD Rise PCL ranks #7 out of 112 companies for PB Ratio. This places SMD Rise PCL in the top 6% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.03. SMD Rise PCL's value of 1.77 is 71.8% above this benchmark. Historically, SMD Rise PCL's own PB Ratio has ranged from 0.34 to 8.95 over the past decade. While the company's 10-year median is 1.27 vs. the industry median of 1.03, SMD Rise PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Distribution company?
The median PB Ratio among Medical Distribution companies is 1.03, based on 112 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SMD Rise PCL's current PB Ratio of 1.77 is 71.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on SMD Rise PCL and its competitors. For the Medical Distribution industry, the median PB Ratio is 1.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SMD Rise PCL's current PB Ratio is 1.77, which is 39% above median its own 10-year median of 1.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SMD Rise PCL stock overvalued right now?
SMD Rise PCL (BKK:SMD100-R) has a current PB Ratio of 1.77. The stock's GF Value™ is ฿23.66, compared to a current price of ฿5.85 — trading 75.3% below its estimated fair value. The current PB Ratio is 1.77, which is 39% above median its 10-year median of 1.27 and 71.8% above the Medical Distribution industry median of 1.03. SMD Rise PCL's overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For SMD Rise PCL (BKK:SMD100-R), the current PB Ratio is 1.77 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SMD Rise PCL (BKK:SMD100-R) Overvalued in 2026?
Based on GuruFocus' analysis, SMD Rise PCL stock appears to be undervalued.
The current stock price of ฿5.85 is trading 75.3% below its estimated GF Value™ of ฿23.66.
Key valuation signals for BKK:SMD100-R:
PB Ratio: 1.77 (39% above median its 10-year median of 1.27)
GF Value™: ฿23.66 vs. price of ฿5.85 (75.3% below fair value)
Industry Position: 71.8% above the Medical Distribution median (#7 of 112)
No single metric tells the full story. See the BKK:SMD100-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Address222,222/1-2 Moo 1, Rattanathibet Road, West Inn Complex Building, 10th Floor, Bang Rak Yai Subdistrict, Bang Bua Thong District, Nonthaburi Province, Bangkok, THA, 11110
SMD Rise PCL, formerly Saintmed PCL is engaged in the import and distribution of medical devices and equipment, rental services for medical equipment, and providing services related to medical equipment. It operates in Thailand. The Group is engaged in three operating segments: Sale of medical devices and equipment, medical supplies, Services of medical equipment at sleep lab centers and repair services, and Revenue from rental of medical equipment at wellness centers and other services. The Group is managed and operates principally in Thailand.
59GF Score
Get the complete analysis for BKK:SMD100-R
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SMD100-R has been successfully added to your 
